PledPharma Broadens Patient Base for the PLIANT Study
Stockholm, 2012-12-19 08:30 CET (GLOBE NEWSWIRE) -- Colorectal cancer is the third most common cancer-related cause of death in the Western world. Standard treatment for metastatic colorectal cancer is the chemotherapy FOLFOX but serious side effects lead to that less than half of the patients receive the recommended dose, and thus are unlikely to fully benefit from the treatment.